A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text

Medicine, Cancer Biology, Molecular Biology +10

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

Tae-Won Kang, Tetyana Yevsa, Norman Woller et al. · Nature · 2011 · 1.6K citations

Medicine, Cell Biology, Oncology +16

Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway

Asim Khwaja, Pablo Rodriguez‐Viciana, Stefan Wennström et al. · The EMBO Journal · 1997 · 1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

Himisha Beltran, David S. Rickman, Kyung Park et al. · Cancer Discovery · 2011 · 1K citations · Full text

Medicine, Molecular Biology, Oncology +17